Observational studyRevista medica del Instituto Mexicano del Seguro Social2025
[Incidence of pulmonary thromboembolism in patients with COVID-19 pneumonia].
Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: COVID-19 disease is an infectious pathology which causes severe respiratory syndrome and it is caused by SARS-CoV-2. On the other hand, pulmonary thromboembolism is one of the most serious and insidious complications, although with a real incidence that is still unknown, especially in patients with COVID-19 pneumonia. Therefore, it is imperative to carry out research to know more information, as well as the relationship it could have with other comorbidities (the most frequent in our population) in order to establish early diagnosis and proper therapy. Objective: To determine the incidence of pulmonary thromboembolism by angiotomography in patients with COVID-19 pneumonia. Material and methods: An analytical, observational, longitudinal, single-center, retrospective and homodemic study was carried out. A total of 71 patients from a public hospital located in the city of Puebla, Mexico, were included. Results: It was determined a cumulative incidence of 0.09 of the patients studied. Male patients were the most affected, with an average age of 65 years. The trunk of the pulmonary artery was the most affected topographic site. Likewise, the most associated comorbidity was diabetes mellitus. Conclusions: There was a similar incidence to that obtained in studies carried out in other parts of the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.